HDAC9 and hematopoietic and lymphoid cell neoplasm: Aberrant HDAC expression occurs in both solid tumors and hematological cancers, including B-cell lymphomas (Ropero and Esteller, 2007; Zain and O’Connor, 2010; Lee et al., 2014).